Abstract
Allograft inflammatory factor-1 (AIF-1) is a 17-kDa IFN- γ inducible Ca2+-binding EF-hand protein involved in immune dysfunction and smooth muscle cell activation. AIF-1 was solubly expressed in E. coli and purified. Crystals of AIF-1 were grown at 291 K using PEG-8000 as precipitant. Diffraction by the AIF-1 crystal extends to 3.3 Å resolution, and the crystal belongs to the space group P43 with unit cell parameters a=b=73.4, c=49.1 Å .
Keywords: Allograft inflammatory factor 1, prokaryotic expression, crystallization
Protein & Peptide Letters
Title: Crystallization and Preliminary Crystallographic Analysis of Allograft Inflammatory Factor 1
Volume: 13 Issue: 8
Author(s): Shentao Li, Xiaoping Liao, Zhangliu Chen and Mark Bartlam
Affiliation:
Keywords: Allograft inflammatory factor 1, prokaryotic expression, crystallization
Abstract: Allograft inflammatory factor-1 (AIF-1) is a 17-kDa IFN- γ inducible Ca2+-binding EF-hand protein involved in immune dysfunction and smooth muscle cell activation. AIF-1 was solubly expressed in E. coli and purified. Crystals of AIF-1 were grown at 291 K using PEG-8000 as precipitant. Diffraction by the AIF-1 crystal extends to 3.3 Å resolution, and the crystal belongs to the space group P43 with unit cell parameters a=b=73.4, c=49.1 Å .
Export Options
About this article
Cite this article as:
Li Shentao, Liao Xiaoping, Chen Zhangliu and Bartlam Mark, Crystallization and Preliminary Crystallographic Analysis of Allograft Inflammatory Factor 1, Protein & Peptide Letters 2006; 13(8) . https://dx.doi.org/10.2174/092986606777841208
DOI https://dx.doi.org/10.2174/092986606777841208 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ribonucleases and ImmunoRNases as Anticancer Drugs
Current Pharmaceutical Design Structure Function Analysis of West Nile Virus RNA Dependent RNA Polymerase: Molecular Model and Implications for Drug Design
Medicinal Chemistry The Utilization of Gene Targeting Models During in Preclinical Study of Drug Discovery Process - Example of Phenotypic and Functional Analysis of Cacna1 βGene Product
Current Pharmaceutical Biotechnology Current and Future Therapies Targeting the Immune System in Multiple Sclerosis
Current Pharmaceutical Biotechnology Editorial [Hot Topic: Protein Peptide Informatics and Drug Designing (Guest Editor: Rajani R. Joshi)]
Protein & Peptide Letters Transgenic Mice as a Model for Alzheimers Disease
Current Alzheimer Research Vaccine Safety Monitoring Systems in Developing Countries: An Example of the Vietnam Model
Current Drug Safety The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Current Drug Targets Autoimmune Diseases and Atherosclerosis: The Inflammatory Connection
Current Immunology Reviews (Discontinued) Antiviral Drug Discovery Targeting to Viral Proteases
Current Pharmaceutical Design New Molecular Targets of Anticancer Therapy – Current Status and Perspectives
Current Medicinal Chemistry From Mice to Macaques – Animal Models of HIV Nervous System Disease
Current HIV Research Ion Channels and Epilepsy
Current Pharmaceutical Design A Role for Leptin in the Systemic Inflammatory Response Syndrome (SIRS) and in Immune Response, an Update
Current Medicinal Chemistry Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
Recent Patents on Anti-Cancer Drug Discovery Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
Current Neuropharmacology In Silico Screening for Potent Inhibitors against the NS3/4A Protease of Hepatitis C Virus
Current Pharmaceutical Design Neuroinflammation in Sepsis: Sepsis Associated Delirium
Cardiovascular & Hematological Disorders-Drug Targets What Animal Models are Best to Test Novel Rheumatoid Arthritis Therapies?
Current Rheumatology Reviews Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives
Current Drug Targets